These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32515121)

  • 1. Successful treatment of tumor necrosis factor inhibitor-resistant cutaneous polyarteritis nodosa with tocilizumab.
    Inoue N; Shimizu M; Mizuta M; Yachie A
    Pediatr Int; 2020 Jun; 62(6):753-755. PubMed ID: 32515121
    [No Abstract]   [Full Text] [Related]  

  • 2. Tocilizumab Treatment in Polyarteritis Nodosa.
    Bodoki L; Végh E; Szekanecz Z; Szűcs G
    Isr Med Assoc J; 2019 Aug; 21(8):560-562. PubMed ID: 31474022
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term follow-up on tocilizumab treatment of AA amyloidosis secondary to polyarteritis nodosa.
    Ostrovršnik J; Hočevar A; Lestan B; Sodin Šemrl S; Lakota K; Tomšič M
    Amyloid; 2016 Dec; 23(4):260-261. PubMed ID: 27791393
    [No Abstract]   [Full Text] [Related]  

  • 4. A young girl with severe polyarteritis nodosa successfully treated with tocilizumab: a case report.
    Boistault M; Lopez Corbeto M; Quartier P; Berbel Arcobé L; Carsi Durall A; Aeschlimann FA
    Pediatr Rheumatol Online J; 2021 Dec; 19(1):168. PubMed ID: 34861842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AA amyloidosis in a polyarteritis nodosa patient treated with tocilizumab.
    Hočevar A; Lestan B; Šemrl SS; Lakota K; Kojc N; Potočnik N; Tomšič M
    Amyloid; 2013 Dec; 20(4):275-6. PubMed ID: 24106820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Young male patient diagnosed with cutaneous polyarteritis nodosa successfully treated with etanercept.
    Valor L; Monteagudo I; de la Torre I; Fernández CG; Montoro M; Longo JL; Carreño L
    Mod Rheumatol; 2014 Jul; 24(4):688-9. PubMed ID: 24981320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Childhood cutaneous polyarteritis nodosa].
    Núñez Giralda A; Espejo Ortega M; Ibáñez Rubio M; Torrelo Fernández A; González Medierod I; López Robledillo J
    An Esp Pediatr; 2001 May; 54(5):506-9. PubMed ID: 11333482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tocilizumab treatment for polyarteritis nodosa.
    Krusche M; Ruffer N; Schneider U; Meyer M; Burmester G; Kötter I
    Rheumatology (Oxford); 2020 Oct; 59(10):e63-e65. PubMed ID: 32182367
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of childhood cutaneous polyarteritis nodosa with infliximab.
    Vega Gutierrez J; Rodriguez Prieto MA; Garcia Ruiz JM
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):570-1. PubMed ID: 17374009
    [No Abstract]   [Full Text] [Related]  

  • 10. Cutaneous polyarteritis nodosa in a child and a review of the literature.
    Mocan H; Mocan MC; Peru H; Ozoran Y
    Acta Paediatr; 1998 Mar; 87(3):351-3. PubMed ID: 9560049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safe and successful treatment of refractory polyarteritis nodosa with tocilizumab in a patient with past hepatitis B virus infection: a case-based review.
    Carrión-Barberà I; Pros A; Salman-Monte TC; Vílchez-Oya F; Sánchez-Schmidt JM; Pérez-García C; Monfort J
    Clin Rheumatol; 2021 May; 40(5):2065-2070. PubMed ID: 32833086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tocilizumab treatment in refractory polyarteritis nodosa: a case report and review of the literature.
    Krusche M; Ruffer N; Kötter I
    Rheumatol Int; 2019 Feb; 39(2):337-344. PubMed ID: 30465270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cutaneous polyarteritis nodosa].
    Turska M; Parada-Turska J
    Wiad Lek; 2018; 71(1 pt 1):73-77. PubMed ID: 29558355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of childhood onset refractory polyarteritis nodosa with tumor necrosis factor alpha blockade.
    Feinstein J; Arroyo R
    J Clin Rheumatol; 2005 Aug; 11(4):219-22. PubMed ID: 16357761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tocilizumab for the treatment of polyarteritis nodosa: a systematic literature review. Correspondence on 'Tofacitinib for polyarteritis nodosa: a tailored therapy' by Rimar
    Akiyama M; Kaneko Y; Takeuchi T
    Ann Rheum Dis; 2022 Oct; 81(10):e204. PubMed ID: 32907804
    [No Abstract]   [Full Text] [Related]  

  • 16. Rescue treatment with tocilizumab for Takayasu arteritis resistant to TNF-α blockers.
    Salvarani C; Magnani L; Catanoso MG; Pipitone N; Versari A; Dardani L; Pulsatelli L; Meliconi R; Boiardi L
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S90-3. PubMed ID: 22410150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulins as treatment of severe cutaneous polyarteritis nodosa.
    Marie I; Miranda S; Girszyn N; Soubrane JC; Vandhuick T; Levesque H
    Intern Med J; 2012 Apr; 42(4):459-62. PubMed ID: 22498120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous polyarteritis nodosa in pediatric patients successfully treated with TNF-α inhibitor and methotrexate: Case series and literature review.
    Do N; Ringold S; Brandling-Bennett H
    Pediatr Dermatol; 2019 Nov; 36(6):932-935. PubMed ID: 31576593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effect of clopidogrel on cutaneous polyarteritis nodosa.
    Kawakami T; Soma Y
    Arch Dermatol; 2010 Jan; 146(1):100-1. PubMed ID: 20083710
    [No Abstract]   [Full Text] [Related]  

  • 20. Infliximab for the treatment of refractory polyarteritis nodosa.
    Ginsberg S; Rosner I; Slobodin G; Rozenbaum M; Kaly L; Jiries N; Boulman N; Awisat A; Hussein H; Novofastovski I; Silawy A; Rimar D
    Clin Rheumatol; 2019 Oct; 38(10):2825-2833. PubMed ID: 30972576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.